Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

628
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
628
Necrosis01:16

Necrosis

6.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.8K
Caspases01:24

Caspases

14.3K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monoallelic PSMB8 variants cause PRAAS with immunodeficiency through impaired immunoproteasome assembly.

American journal of human genetics·2026
Same author

From CVID to PIRD: Genetic Testing Leading to Signal Transducer and Activator of Transcription 3 Gain-of-Function Diagnosis and Directed Therapy.

The journal of allergy and clinical immunology. In practice·2026
Same author

Kidney Transplant Outcomes in Coatomer Protein Complex Subunit Alpha (COPA) Syndrome: Report of Five Patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

TNFSF13 insufficiency disrupts human colonic epithelial cell growth and associated B cell dynamics.

The Journal of clinical investigation·2026
Same author

Tonsillar expression quantitative trait loci verify and expand genetic contributors to childhood atopic diseases.

bioRxiv : the preprint server for biology·2026
Same author

Unmanipulated bone marrow infusion without conditioning can rescue <i>RECQL4</i> <sup>-/-</sup> severe combined immunodeficiency.

Journal of human immunity·2026
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Related Experiment Video

Updated: Feb 22, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

11.3K

NLRC4 inflammasomopathies.

Neil Romberg1, Tiphanie P Vogel, Scott W Canna

  • 1aDivision of Immunology and Allergy, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania bDivison of Immunology, Allergy and Rheumatology, Department of Pediatrics, Baylor College of Medicine and Center for Human Immunobiology, Texas Children's Hospital, Houston, Texas cRK Mellon Institute for Pediatric Research/Pediatric Rheumatology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, USA.

Current Opinion in Allergy and Clinical Immunology
|September 29, 2017
PubMed
Summary
This summary is machine-generated.

Gain-of-function mutations in NLRC4 cause autoinflammatory diseases, expanding beyond infantile enterocolitis to include conditions like NOMID. Early diagnosis and targeted therapies improve outcomes for these NLRC4-inflammasomopathies.

More Related Videos

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1&#946; in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

21.4K
Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
08:41

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages

Published on: April 6, 2022

3.2K

Related Experiment Videos

Last Updated: Feb 22, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

11.3K
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1&#946; in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

21.4K
Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
08:41

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages

Published on: April 6, 2022

3.2K

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Autoinflammatory diseases are characterized by dysregulated innate immunity.
  • Gain-of-function mutations in NLR-family CARD-containing protein 4 (NLRC4) lead to a spectrum of inflammatory conditions.
  • Understanding the NLRC4 inflammasome's role is crucial for developing targeted therapies.

Purpose of the Study:

  • To review recent advancements in understanding NLRC4-inflammasomopathies.
  • To highlight the clinical spectrum and genetic basis of these diseases.
  • To discuss emerging therapeutic strategies for affected patients.

Main Methods:

  • Literature review of studies on NLRC4-related autoinflammatory diseases.
  • Analysis of clinical phenotypes, genetic mutations, and treatment outcomes.
  • Focus on the role of the NLRC4 inflammasome and IL-18 signaling.

Main Results:

  • NLRC4 inflammasome activation contributes to gut inflammation in myeloid and intestinal epithelial cells.
  • New therapeutic targets include IL-18 binding protein and anti-interferon-γ antibodies.
  • Phenotypes like familial cold autoinflammatory syndrome and NOMID are now linked to NLRC4 mutations.
  • Somatic mosaicism in NLRC4 was identified in patients with NOMID and AIFEC, indicating novel inheritance patterns.

Conclusions:

  • NLRC4-inflammasomopathies represent a growing category of autoinflammatory diseases with a wide clinical range.
  • Early identification using biomarkers such as elevated IL-18 is vital.
  • Prompt intervention with immunomodulatory therapies can significantly improve patient outcomes, especially for severe forms like AIFEC.